Back to News & Events

Crowne Plaza Times Square Manhattan

Location


1605 Broadway
New York
NY
10019

Next Event

No upcoming events

Loading Map….

Upcoming Events

  • No events in this location
  • Related Stories

    WP_Query Object
    (
        [query] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
            )
    
        [query_vars] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
                [error] => 
                [m] => 
                [p] => 0
                [post_parent] => 
                [subpost] => 
                [subpost_id] => 
                [attachment] => 
                [attachment_id] => 0
                [name] => 
                [pagename] => 
                [page_id] => 0
                [second] => 
                [minute] => 
                [hour] => 
                [day] => 0
                [monthnum] => 0
                [year] => 0
                [w] => 0
                [category_name] => 
                [tag] => 
                [cat] => 
                [tag_id] => 
                [author] => 
                [author_name] => 
                [feed] => 
                [tb] => 
                [paged] => 0
                [meta_key] => 
                [meta_value] => 
                [preview] => 
                [s] => 
                [sentence] => 
                [title] => 
                [fields] => 
                [menu_order] => 
                [embed] => 
                [category__in] => Array
                    (
                    )
    
                [category__not_in] => Array
                    (
                    )
    
                [category__and] => Array
                    (
                    )
    
                [post__in] => Array
                    (
                    )
    
                [post__not_in] => Array
                    (
                    )
    
                [post_name__in] => Array
                    (
                    )
    
                [tag__in] => Array
                    (
                    )
    
                [tag__not_in] => Array
                    (
                    )
    
                [tag__and] => Array
                    (
                    )
    
                [tag_slug__in] => Array
                    (
                    )
    
                [tag_slug__and] => Array
                    (
                    )
    
                [post_parent__in] => Array
                    (
                    )
    
                [post_parent__not_in] => Array
                    (
                    )
    
                [author__in] => Array
                    (
                    )
    
                [author__not_in] => Array
                    (
                    )
    
                [search_columns] => Array
                    (
                    )
    
                [ignore_sticky_posts] => 
                [suppress_filters] => 
                [cache_results] => 1
                [update_post_term_cache] => 1
                [update_menu_item_cache] => 
                [lazy_load_term_meta] => 1
                [update_post_meta_cache] => 1
                [nopaging] => 
                [comments_per_page] => 50
                [no_found_rows] => 
                [order] => 
            )
    
        [tax_query] => WP_Tax_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => AND
                [table_aliases:protected] => Array
                    (
                    )
    
                [queried_terms] => Array
                    (
                    )
    
                [primary_table] => wp_posts
                [primary_id_column] => ID
            )
    
        [meta_query] => WP_Meta_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => 
                [meta_table] => 
                [meta_id_column] => 
                [primary_table] => 
                [primary_id_column] => 
                [table_aliases:protected] => Array
                    (
                    )
    
                [clauses:protected] => Array
                    (
                    )
    
                [has_or_relation:protected] => 
            )
    
        [date_query] => 
        [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
    					 FROM wp_posts 
    					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
    					 
    					 ORDER BY RAND()
    					 LIMIT 0, 3
        [posts] => Array
            (
                [0] => WP_Post Object
                    (
                        [ID] => 4439
                        [post_author] => 3
                        [post_date] => 2024-07-30 15:29:07
                        [post_date_gmt] => 2024-07-30 19:29:07
                        [post_content] => 
    

    CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

    The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

    Read more about IAMBIC and their recent funding here.

    [post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-11-19 10:50:15 [post_modified_gmt] => 2024-11-19 15:50:15 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 2706 [post_author] => 3 [post_date] => 2017-06-02 14:04:51 [post_date_gmt] => 2017-06-02 14:04:51 [post_content] => Dr. Sasha Levy, Marsha Laufer Endowed Assistant Professor of Physical and Quantitative Biology for the Laufer Center and the Department of Biochemistry & Cell Biology at Stony Brook University, recently had an article published in Nature Communications related to his research supported by the Long Island Bioscience Hub. In the article, Dr. Levy’s group has described a next-generation high-throughput system for studying protein-protein interactions in yeast, without the limitations of previous techniques, by monitoring relative barcode frequencies across time periods. This allows large scale study of protein interaction changes across dynamic environments, and can be used for rapid drug screening assays. Access the article here. [post_title] => LIBH Researcher Published in Nature Communications [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => libh-researcher-published-in-nature-communications [to_ping] => [pinged] => [post_modified] => 2017-06-02 14:04:51 [post_modified_gmt] => 2017-06-02 14:04:51 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2706 [menu_order] => 144 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2039 [post_author] => 3 [post_date] => 2016-03-24 18:53:40 [post_date_gmt] => 2016-03-24 18:53:40 [post_content] => News 12 Long Island Recently highlighted Katarzyna Sawicka, Founder and President of ImmunoMatrix, a Stony Brook start-up and CFB client developing a technology that can deliver medication directly through the skin, no needles necessary. View the segment here. [post_title] => “No More Needles” – News 12 LI Features ImmunoMatrix [post_excerpt] => News 12 Long Island Recently highlighted Katarzyna Sawicka, Founder and President of ImmunoMatrix, a Stony Brook start-up and CFB client developing a technology that can deliver medication directly through the skin, no needles necessary. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => no-more-needles-news-12-li-features-immunomatrix [to_ping] => [pinged] => [post_modified] => 2016-03-29 20:30:02 [post_modified_gmt] => 2016-03-29 20:30:02 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2039 [menu_order] => 187 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 2667 [post_author] => 3 [post_date] => 2017-04-20 18:25:21 [post_date_gmt] => 2017-04-20 18:25:21 [post_content] => The Center for Biotechnology's Clint Rubin and Diane Fabel recently co-authored a STAT article on the NIH-REACH proof-of-concept program. In 2015, The Center for Biotechnology received one of three national NIH-REACH designations, through which the Long Island Bioscience Hub was established. The article, co-authored by all of the REACH center directors, discusses the importance of REACH-type programs and the impact REACH has been able have in a relatively short amount of time. In just over two years, the three REACH institutions have evaluated over 400 promising product development projects, funding more than 60 experimental treatments and tests that target a wide range of health issues. Read the full text here: https://www.statnews.com/2017/04/17/nih-reach-biomedicine-treatments/ [post_title] => NIH-REACH: Lowering the Barriers that Slow Translation Research [post_excerpt] => Recent STAT article on the NIH-REACH proof-of-concept program authored by CFB's Clinton Rubin and Diane Fabel. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => nih-reach-lowering-the-barriers-that-slow-translation-research [to_ping] => [pinged] => [post_modified] => 2017-05-05 19:57:47 [post_modified_gmt] => 2017-05-05 19:57:47 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2667 [menu_order] => 150 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4439 [post_author] => 3 [post_date] => 2024-07-30 15:29:07 [post_date_gmt] => 2024-07-30 19:29:07 [post_content] =>

    CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

    The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

    Read more about IAMBIC and their recent funding here.

    [post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-11-19 10:50:15 [post_modified_gmt] => 2024-11-19 15:50:15 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 261 [max_num_pages] => 87 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

    CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant

    More Information

    LIBH Researcher Published in Nature Communications

    More Information

    “No More Needles” – News 12 LI Features ImmunoMatrix

    More Information

    NIH-REACH: Lowering the Barriers that Slow Translation Research

    More Information